Robin Strongin - Academia.edu (original) (raw)

Papers by Robin Strongin

Research paper thumbnail of How Vulnerable Is the Nation\u27s Food Supply? Linking Food Safety and Food Security

This paper reviews the food safety regulatory apparatus in place today, especially the activities... more This paper reviews the food safety regulatory apparatus in place today, especially the activities of the two lead agencies in assuring food safety — the Food and Drug Administration within the Department of Health and Human Services and the Food Safety and Inspection Service within the Department of Agriculture. It examines the system\u27s strengths and vulnerabilities, particularly in light of the post–September 11 environment that includes the heightened threat of terrorism. The paper also touches upon legislative and budgetary proposals aimed at improving food security, including the growing but debated interest in a single food safety agency

Research paper thumbnail of State-based pharmaceutical assistance programs: temporary fix or lessons for Medicare?

Issue brief (George Washington University. National Health Policy Forum), Jan 25, 2001

Research paper thumbnail of Physician connectivity: electronic prescribing

Issue brief (George Washington University. National Health Policy Forum), Jan 23, 2000

Research paper thumbnail of The ABCs of PBMs

Issue brief (George Washington University. National Health Policy Forum), Jan 27, 1999

NHPF is a nonpartisan education and information exchange for federal health policymakers. The ABC... more NHPF is a nonpartisan education and information exchange for federal health policymakers. The ABCs of PBMs As Congress continues to consider adding an outpatient prescription drug benefit for Medicare beneficiaries in this presidential election year, the number of administrative and legislative proposals goes on climbing. While the nature and scope of these proposals vary widely, they all contain a common element, the use of PBMs-pharmacy benefit managers. By acting as intermediaries between pharmaceutical manufacturers and third-party payers (that is, employers, managed care organizations, labor unions, and state-funded pharmaceutical assistance programs for the elderly), PBMs administer prescription drug benefits. A major policy and, indeed, practical consideration, will be the degree of latitude provided a PBM in managing a Medicare outpatient drug benefit. Interventions Consumer behavior modification Enhanced patient interventions Physician connectivity Clinical consulting Disease management DUR, including retrospective Mail Retail intervention Drug interaction Manufacturer Competitive rebate contracts Base Services Patient information system Member level data Physician level data Efficient transaction processing Pharmacy network Mail service fulfillment Interventions MSA DUR Mail Retail intervention Drug interaction Manufacturer Competitive rebate contracts Base Services Efficient transaction processing Pharmacy network Mail service fulfillment Interventions Physician connectivity Clinical consulting Retrospective DUR Disease management DUR, including retrospective Retail intervention Drug interaction Manufacturer Competitive rebate contracts Base Services Member level data Physician level data Efficient transaction processing Pharmacy network Mail service fulfillment Intervention Drug interaction Base Services Efficient transaction processing Pharmacy network Mail service fulfillment 1980s Efficient Benefit Administration Early 1990s Cost and Clinical Control Mid 1990s Improved Outcomes through Information

Research paper thumbnail of Medicare coverage and technology diffusion: past, present, and future

Issue brief (George Washington University. National Health Policy Forum), Jan 9, 1998

Research paper thumbnail of The truth about technology and health care costs

IEEE Technology and Society Magazine, 1996

In the US, the health care cost problem is both complex and critical, since it will shape the dir... more In the US, the health care cost problem is both complex and critical, since it will shape the direction of future policies for health care delivery and financing systems. This debate over health care cost inflation often centers on the role of medical technology. The paper discusses the role of technology in rising health care costs.

Research paper thumbnail of Providing outpatient prescription drugs through Medicare: can we afford to? Can we afford not to?

Issue brief (George Washington University. National Health Policy Forum), Jan 8, 1999

Research paper thumbnail of Bioterrorism: Summary of a CRS/National Health Policy Forum Seminar on Federal, State, and Local Public Health Preparedness

The September 11 th attack and subsequent intentional release of anthrax spores via the U.S. post... more The September 11 th attack and subsequent intentional release of anthrax spores via the U.S. postal system have focused policymakers' attention on the preparedness and response capability of the nation's public health system. The anthrax attacks put a tremendous strain on the U. S. public health infrastructure, an infrastructure that many experts argue has been weakened by years of neglect and under-funding. To better understand the preparedness gaps that exist, as well as the disparate functions and agencies that define public health in this country,

Research paper thumbnail of Biological terrorism: is the health care community prepared?

Issue brief (George Washington University. National Health Policy Forum), Jan 11, 1999

Research paper thumbnail of Who will pay for the adverse events resulting from smallpox vaccination? Liability and compensation issues

NHPF issue brief, 2003

This paper summarizes liability and compensation concerns surrounding the smallpox vaccination pr... more This paper summarizes liability and compensation concerns surrounding the smallpox vaccination program announced by President Bush on December 13, 2002. The paper examines the nature of adverse health events that are likely to occur in connection with the smallpox vaccine, assesses the liability protections that have been established for organizations and individuals participating in the vaccination program, and discusses the compensation mechanisms being considered to address the damages incurred by volunteers who may suffer from adverse vaccine reactions. Specifically, the implications of the Federal Tort Claims Act, workers' compensation programs, and the creation of a new no-fault compensation fund are explored.

Research paper thumbnail of How vulnerable is the nation's food supply? Linking food safety and food security

NHPF issue brief, 2002

This paper reviews the food safety regulatory apparatus in place today. It examines the system&#3... more This paper reviews the food safety regulatory apparatus in place today. It examines the system's strengths and vulnerabilities, particularly in light of the post-September 11 environment that includes the added threat of terrorism. The paper touches upon legislative and budgetary proposals aimed at improving food security, including the growing but debated interest in a single food safety agency.

Research paper thumbnail of Medicare Coverage: Lessons from the Past, Questions for the Future

NHPF is a nonpartisan education and information exchange for federal health policymakers. Overvie... more NHPF is a nonpartisan education and information exchange for federal health policymakers. Overview-This paper describes the Medicare coverage process for emerging technologies and the ways it has changed over time. Issues addressed include both the national coverage process and local medical review policies, which account for 90 percent of the coverage determinations. The paper also includes a discussion of the relationship between the coverage process and technology assessment, payment systems and the ongoing debate over coverage criteria and levels of evidence.

Research paper thumbnail of U.S. childhood vaccine availability: legal, regulatory, and economic complexities

NHPF issue brief, 2002

Despite the vital role they play in public health, childhood vaccines travel a complicated road f... more Despite the vital role they play in public health, childhood vaccines travel a complicated road from laboratory to provider and patient. From the fall of 2000 until well into 2002, a combination of factors, including market dynamics, legal challenges, and regulatory hurdles, led to a shortage of some childhood vaccines. This paper examines each of these factors, focusing on the important roles of both the public and the private sectors.

Research paper thumbnail of Table 1 Mergers and Acquisitions in the Pharmaceutical Industry 2000

Research paper thumbnail of Emergency Preparedness from a Health Perspective: Preparing for Bioterrorism at the Federal, State, and Local Levels

A background paper, with resource lists, prepared by Robin J. Strongin, Consultant 2 BACKGROUND P... more A background paper, with resource lists, prepared by Robin J. Strongin, Consultant 2 BACKGROUND PAPER

Research paper thumbnail of Hatch-Waxman, Generics, and Patents: Balancing Prescription Drug Innovation, Competition, and Affordability

OVERVIEW-This paper explores the complex connections among intellectual property protection, comp... more OVERVIEW-This paper explores the complex connections among intellectual property protection, competition, and access to affordable prescription drug products. It focuses on several provisions of the Drug Price Competition and Patent Term Restoration Act of 1984 (Hatch-Waxman) and discusses the debate swirling around its reform. An overview of landmark intellectual property laws and a description of the generic drug approval process are also included.

Research paper thumbnail of Site Visit to Baltimore and Fort Detrick, Maryland — Preparing for a Bioterrorist Incident: Linking the Public Health and Medical Communities

Research paper thumbnail of Who will pay for the adverse events resulting from smallpox vaccination? Liability and compensation issues

NHPF Issue Brief, 2003

OVERVIEW — This paper summarizes liability and compensation concerns surrounding the smallpox vac... more OVERVIEW — This paper summarizes liability and compensation concerns surrounding the smallpox vaccination program announced by President Bush on December 13, 2002. The paper examines the nature of adverse health events that are likely to occur in connection with ...

Research paper thumbnail of How Vulnerable Is the Nation\u27s Food Supply? Linking Food Safety and Food Security

This paper reviews the food safety regulatory apparatus in place today, especially the activities... more This paper reviews the food safety regulatory apparatus in place today, especially the activities of the two lead agencies in assuring food safety — the Food and Drug Administration within the Department of Health and Human Services and the Food Safety and Inspection Service within the Department of Agriculture. It examines the system\u27s strengths and vulnerabilities, particularly in light of the post–September 11 environment that includes the heightened threat of terrorism. The paper also touches upon legislative and budgetary proposals aimed at improving food security, including the growing but debated interest in a single food safety agency

Research paper thumbnail of State-based pharmaceutical assistance programs: temporary fix or lessons for Medicare?

Issue brief (George Washington University. National Health Policy Forum), Jan 25, 2001

Research paper thumbnail of Physician connectivity: electronic prescribing

Issue brief (George Washington University. National Health Policy Forum), Jan 23, 2000

Research paper thumbnail of The ABCs of PBMs

Issue brief (George Washington University. National Health Policy Forum), Jan 27, 1999

NHPF is a nonpartisan education and information exchange for federal health policymakers. The ABC... more NHPF is a nonpartisan education and information exchange for federal health policymakers. The ABCs of PBMs As Congress continues to consider adding an outpatient prescription drug benefit for Medicare beneficiaries in this presidential election year, the number of administrative and legislative proposals goes on climbing. While the nature and scope of these proposals vary widely, they all contain a common element, the use of PBMs-pharmacy benefit managers. By acting as intermediaries between pharmaceutical manufacturers and third-party payers (that is, employers, managed care organizations, labor unions, and state-funded pharmaceutical assistance programs for the elderly), PBMs administer prescription drug benefits. A major policy and, indeed, practical consideration, will be the degree of latitude provided a PBM in managing a Medicare outpatient drug benefit. Interventions Consumer behavior modification Enhanced patient interventions Physician connectivity Clinical consulting Disease management DUR, including retrospective Mail Retail intervention Drug interaction Manufacturer Competitive rebate contracts Base Services Patient information system Member level data Physician level data Efficient transaction processing Pharmacy network Mail service fulfillment Interventions MSA DUR Mail Retail intervention Drug interaction Manufacturer Competitive rebate contracts Base Services Efficient transaction processing Pharmacy network Mail service fulfillment Interventions Physician connectivity Clinical consulting Retrospective DUR Disease management DUR, including retrospective Retail intervention Drug interaction Manufacturer Competitive rebate contracts Base Services Member level data Physician level data Efficient transaction processing Pharmacy network Mail service fulfillment Intervention Drug interaction Base Services Efficient transaction processing Pharmacy network Mail service fulfillment 1980s Efficient Benefit Administration Early 1990s Cost and Clinical Control Mid 1990s Improved Outcomes through Information

Research paper thumbnail of Medicare coverage and technology diffusion: past, present, and future

Issue brief (George Washington University. National Health Policy Forum), Jan 9, 1998

Research paper thumbnail of The truth about technology and health care costs

IEEE Technology and Society Magazine, 1996

In the US, the health care cost problem is both complex and critical, since it will shape the dir... more In the US, the health care cost problem is both complex and critical, since it will shape the direction of future policies for health care delivery and financing systems. This debate over health care cost inflation often centers on the role of medical technology. The paper discusses the role of technology in rising health care costs.

Research paper thumbnail of Providing outpatient prescription drugs through Medicare: can we afford to? Can we afford not to?

Issue brief (George Washington University. National Health Policy Forum), Jan 8, 1999

Research paper thumbnail of Bioterrorism: Summary of a CRS/National Health Policy Forum Seminar on Federal, State, and Local Public Health Preparedness

The September 11 th attack and subsequent intentional release of anthrax spores via the U.S. post... more The September 11 th attack and subsequent intentional release of anthrax spores via the U.S. postal system have focused policymakers' attention on the preparedness and response capability of the nation's public health system. The anthrax attacks put a tremendous strain on the U. S. public health infrastructure, an infrastructure that many experts argue has been weakened by years of neglect and under-funding. To better understand the preparedness gaps that exist, as well as the disparate functions and agencies that define public health in this country,

Research paper thumbnail of Biological terrorism: is the health care community prepared?

Issue brief (George Washington University. National Health Policy Forum), Jan 11, 1999

Research paper thumbnail of Who will pay for the adverse events resulting from smallpox vaccination? Liability and compensation issues

NHPF issue brief, 2003

This paper summarizes liability and compensation concerns surrounding the smallpox vaccination pr... more This paper summarizes liability and compensation concerns surrounding the smallpox vaccination program announced by President Bush on December 13, 2002. The paper examines the nature of adverse health events that are likely to occur in connection with the smallpox vaccine, assesses the liability protections that have been established for organizations and individuals participating in the vaccination program, and discusses the compensation mechanisms being considered to address the damages incurred by volunteers who may suffer from adverse vaccine reactions. Specifically, the implications of the Federal Tort Claims Act, workers' compensation programs, and the creation of a new no-fault compensation fund are explored.

Research paper thumbnail of How vulnerable is the nation's food supply? Linking food safety and food security

NHPF issue brief, 2002

This paper reviews the food safety regulatory apparatus in place today. It examines the system&#3... more This paper reviews the food safety regulatory apparatus in place today. It examines the system's strengths and vulnerabilities, particularly in light of the post-September 11 environment that includes the added threat of terrorism. The paper touches upon legislative and budgetary proposals aimed at improving food security, including the growing but debated interest in a single food safety agency.

Research paper thumbnail of Medicare Coverage: Lessons from the Past, Questions for the Future

NHPF is a nonpartisan education and information exchange for federal health policymakers. Overvie... more NHPF is a nonpartisan education and information exchange for federal health policymakers. Overview-This paper describes the Medicare coverage process for emerging technologies and the ways it has changed over time. Issues addressed include both the national coverage process and local medical review policies, which account for 90 percent of the coverage determinations. The paper also includes a discussion of the relationship between the coverage process and technology assessment, payment systems and the ongoing debate over coverage criteria and levels of evidence.

Research paper thumbnail of U.S. childhood vaccine availability: legal, regulatory, and economic complexities

NHPF issue brief, 2002

Despite the vital role they play in public health, childhood vaccines travel a complicated road f... more Despite the vital role they play in public health, childhood vaccines travel a complicated road from laboratory to provider and patient. From the fall of 2000 until well into 2002, a combination of factors, including market dynamics, legal challenges, and regulatory hurdles, led to a shortage of some childhood vaccines. This paper examines each of these factors, focusing on the important roles of both the public and the private sectors.

Research paper thumbnail of Table 1 Mergers and Acquisitions in the Pharmaceutical Industry 2000

Research paper thumbnail of Emergency Preparedness from a Health Perspective: Preparing for Bioterrorism at the Federal, State, and Local Levels

A background paper, with resource lists, prepared by Robin J. Strongin, Consultant 2 BACKGROUND P... more A background paper, with resource lists, prepared by Robin J. Strongin, Consultant 2 BACKGROUND PAPER

Research paper thumbnail of Hatch-Waxman, Generics, and Patents: Balancing Prescription Drug Innovation, Competition, and Affordability

OVERVIEW-This paper explores the complex connections among intellectual property protection, comp... more OVERVIEW-This paper explores the complex connections among intellectual property protection, competition, and access to affordable prescription drug products. It focuses on several provisions of the Drug Price Competition and Patent Term Restoration Act of 1984 (Hatch-Waxman) and discusses the debate swirling around its reform. An overview of landmark intellectual property laws and a description of the generic drug approval process are also included.

Research paper thumbnail of Site Visit to Baltimore and Fort Detrick, Maryland — Preparing for a Bioterrorist Incident: Linking the Public Health and Medical Communities

Research paper thumbnail of Who will pay for the adverse events resulting from smallpox vaccination? Liability and compensation issues

NHPF Issue Brief, 2003

OVERVIEW — This paper summarizes liability and compensation concerns surrounding the smallpox vac... more OVERVIEW — This paper summarizes liability and compensation concerns surrounding the smallpox vaccination program announced by President Bush on December 13, 2002. The paper examines the nature of adverse health events that are likely to occur in connection with ...